Skip to content

Don't take Ginkgo biloba with efavirenz

No change in HIV virulence in French cohort

High prevalence of lipodystropy amongst patients taking HIV treatment in Senegal: d4T sole risk factor

Single DNA change may identify susceptibility to tenofovir-related kidney damage

Switching from efavirenz to nevirapine in women with higher CD4 counts

HIV treatment reduces liver damage in HIV/HCV co-infected patients

Average viral load in the community predicts HIV incidence in drug users

HIV treatment does not increase the risk of fractures

Gates Foundation to fund trial of lower efavirenz dose